Bayer, a German multinational pharmaceutical and agrochemical company, announced a reduction in its second-quarter net loss to €34 million ($37 million) from €1.89 billion a year earlier. Earnings before interest, tax, depreciation and amortization (EBITDA) before special items decreased by 16.5% to €2.1 billion. The decline in earnings was mainly due to an unfavorable product mix. In addition, the provisions for the group-wide short-term incentive program were lower in the prior-year period. Earnings before interest and taxes (EBIT) improved to €525 million from minus €956 million last year. …